ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression

Mao, Chengqiong; Yeh, Stacy; Fu, Juan; Porosnicu, Mercedes; Thomas, Alexandra; Kucera, Gregory L.; Votanopoulos, Konstantinos, I; Tian, Shaomin; Ming, Xin*
Science Translational Medicine2022-6-8DOI: 10.1126/scitranslmed.abh1261
29被引8阅读
引用收藏
分享

摘要

Tumor evasion of immune destruction is associated with the production of immunosuppressive adenosine in the tumor microenvironment (TME). Anticancer therapies can trigger adenosine triphosphate (ATP) release from tumor cells, causing rapid formation of adenosine by the ectonucleotidases CD39 and CD73, thereafter exacerbating immunosuppression in the TME. The goal of this study was to develop an approach to facilitate cancer therapy-induced immunogenic cell death including ATP release and to limit ATP degradation into adenosine, in order to achieve durable antitumor immune response. Our approach was to construct reactive oxygen species (ROS)-producing nanoparticles that carry an ectonucleotidase inhibitor ARL67156 by electronic interaction and phenylboronic ester. Upon near-infrared irradiation, nanoparticle-produced ROS induced ATP release from MOC1 cancer cells in vitro and triggered the cleavage of phenylboronic ester, facilitating the release of ARL67156 from the nanoparticles. ARL67156 prevented conversion of ATP to adenosine and enhanced anticancer immunity in an MOC1-based coculture model. We tested this approach in mouse tumor models. Nanoparticle-based ROS-responsive drug delivery reprogramed the immunogenic landscape in tumors, eliciting tumor-specific T cell responses and tumor regression, conferring long-term survival in mouse models. We demonstrated that TME reprograming sets the stage for response to anti-programmed cell death protein 1 (PD1) immunotherapy, and the combination resulted in tumor regression in a 4T1 breast cancer mouse model that was resistant to PD1 blockade. Furthermore, our approach also induced immunological effects in patient-derived organotypic tumor spheroid model, suggesting potential translation of our nanoparticle approach for treating human cancers.

学科与关键词

关键词
IMMUNOGENIC CELL-DEATHREGULATORY T-CELLSCD39CD73IMMUNOTHERAPYRESISTANCETUMORSATPSUPPRESSIONMECHANISMS
相关
加载中…
  • DNA damage-encouraged Mn-As-based nanoreactors reshape intratumoral cell phenotypes to recover immune surveillance and potentiate anti-tumor immunity
    Zhao, Qing; Dong, Xiulin; Zhu, Chunyan; Zhang, Yan; Fang, Chao; Zhou, Xianli*; Zhang, Kun*; Zhou, HangChemical Engineering Journal, 2023, 474: 145556.被引 1
  • A Sub-6 nm MnFe2O4-dichloroacetic acid nanocomposite modulates tumor metabolism and catabolism for reversing tumor immunosuppressive microenvironment and boosting immunotherapy
    Dai, Zan; Wang, Qiaoyun; Tang, Jie*; Qu, Rui; Wu, Min; Li, Haoze; Yang, Yannan; Zhen, Xu*; Yu, Chengzhong*Biomaterials, 2022, 284: 121533.被引 17
  • Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib
    Sun, Xu; Cao, Ziyang; Mao, Kuirong; Wu, Chenxi; Chen, Hongmei; Wang, Jialiang; Wang, Xin; Cong, Xiuxiu; Li, Yong; Meng, Xianying*; Yang, Xianzhu*; Yang, Yong-Guang*; Sun, Tianmeng*Biomaterials, 2020, 240: 119845.被引 58
查看全部 →

发表信息

论文状态
公开发表
期刊
Science Translational Medicine
发表日期
2022-06-08
卷期
第 14 卷, 第 648 期
页码
eabh1261
DOI
10.1126/scitranslmed.abh1261
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
NIH [R01CA194064, R21CA267853, R21CA263759]; Wake Forest Baptist Comprehensive Cancer Center - NCI [P30CA012197]; Wake Forest Clinical and Translational Science Institute - Clinical and Translational Science Award from the NIH [UL1TR001420]

作者

  • M

    Mao, Chengqiong (第一作者)

  • Y

    Yeh, Stacy

查看全部 9 位作者收起作者
  • F

    Fu, Juan

  • P

    Porosnicu, Mercedes

  • T

    Thomas, Alexandra

  • K

    Kucera, Gregory L.

  • V

    Votanopoulos, Konstantinos, I

  • T

    Tian, Shaomin

  • M

    Ming, Xin (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417